| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $387K | +8.79K | +17.08% | $44.09* | 60.2K | Sep 7, 2023 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$1.81M | -8.79K | -14.59% | $205.76 | 51.4K | Sep 7, 2023 | Direct | F1, F2, F3 |
| holding | SGEN | Common Stock | 119K | Sep 7, 2023 | by Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -8.79K | -24.93% | $0.00 | 26.4K | Sep 7, 2023 | Common Stock | 8.79K | $44.09 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a written plan, entered into on 11/29/22, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $205.40 to $206.17. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Options vested at a rate of 25% on 8/26/15 and monthly thereafter until all the options were fully vested on 08/26/18. |